gif-img
Services »

Translational Informatics and Biometrics

Unlock the power of your multiomic data

FPO

Unlocking the Value of Complex Biomarker Data: Clinical Omics

In this article, our experts are asked to explore biomarker data trends and
challenges, and share how drug developers evaluating biomarkers in
early-phase studies can quickly realize the full value of the collected data.

Read Now

The proliferation of biomarker data presents a massive challenge for teams compiling data sets from multiple labs covering several assay types and numerous time points. Today’s multiomic approach demands the harmonization of these data sets as well as relevant clinical annotation for subsequent interrogation–including leveraging the power of artificial intelligence-driven analysis. QuartzBioSM is the market leader in unraveling biomarker and meta data to generate actionable, analytic-ready data sets.

Multiomic data integration and informatics

  • Leverage deep domain expertise to harmonize large, complex multiomic data sets within and across trials (covering flow cytometry, genomics, gene expression profiling, imaging, clinical annotations, and beyond)
  • Dramatically reduce time to consolidate data from multiple labs for internal analysis–from days or weeks to minutes–to maximize on-study utility
  • Create analysis- and submission-ready data sets (including CDISC) using a secure 21 CFR Part 11 compliant infrastructure
  • Generate AI-derived signatures across integrated omic data sets and explore results in an intuitive, interpretable, and interactive interface

Comprehensive multiomic data ingestion, harmonization, and the ability to uncover mechanisms of action, identify biomarkers, and stratify patients

Find out more about QuartzBio

The expertise and operational scale to support biomarker-guided drug discovery and development efforts

Precision Medicine Group is an integrated team of experts in fields from advanced lab sciences to translational informatics and regulatory affairs, payer insights to marketing communications. Together, we help our pharmaceutical and life-sciences clients conquer product development and commercialization challenges in a rapidly evolving environment.